ArticleProceedings of the National Academy of Sciences of the United States of America2015

Human anti-nucleolin recombinant immunoagent for cancer therapy.

Dario Palmieri et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.